Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
becaplermin (regranex) (1 trial)
Diabetic Foot (Phase 2)
Foot Ulcer (Phase 2)
Ulcer (Phase 2)
Trials (1 total)
Trial APIs (1 total)